FDA Submits Collection of Information for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its efforts to review and approve new animal drugs for minor use and minor species.